• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Fat Tissue Attenuation and CT-FFR Linked to Coronary Progression

by
November 14, 2026
in Health
Reading Time: 5 mins read
0
Fat Tissue Attenuation and CT-FFR Linked to Coronary Progression

Fat Tissue Attenuation and CT-FFR Linked to Coronary Progression

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a retrospective single-center study published in Frontiers in Cardiovascular Medicine, researchers identified specific imaging markers associated with the progression of non-obstructive coronary artery disease. The study, conducted at The First Hospital of Shanxi Medical University in Taiyuan, China, analyzed serial coronary computed tomography angiography (CCTA) data from 201 patients. The central finding indicates that less-negative pericoronary adipose tissue (PCAT) attenuation and lower CT-derived fractional flow reserve (CT-FFR) values were statistically associated with imaging-defined stenosis progression over an examination interval of 18 to 30 months. This work addresses a clinical gap where luminal stenosis alone fails to capture local tissue characteristics or lesion-specific functional impairment in patients whose baseline disease is classified as minimal or mild.

The research team, led by Jun Wang and Zengyu Jiang, aimed to evaluate the associations of lesion-specific PCAT attenuation and CT-FFR with stenosis progression. Coronary atherosclerosis is a dynamic process, and non-obstructive disease at baseline is not benign, as event risk increases with the extent of such disease. While serial CCTA studies have previously related plaque characteristics to subsequent events, the interpretation of lesion-specific PCAT measurements depends on reproducible lesion and region-of-interest definitions. CT-FFR estimates lesion-specific hemodynamic impairment from CCTA, representing a functional assessment distinct from anatomical stenosis grading. The study sought to determine if these distinct imaging domains could jointly predict progression before severe obstruction develops.

The study design was observational and retrospective, including adults who underwent baseline and follow-up CCTA between January 2020 and December 2023. Eligibility required at least one baseline atherosclerotic plaque and evaluable serial images sufficient to classify stenosis progression. Patients with any coronary stenosis of 50% or greater at baseline were excluded. The analyzed target lesions were classified as minimal (1% to 24%) or mild (25% to 49%) stenosis. A critical methodological feature was the outcome-dependent target-lesion selection: in patients who progressed, the lesion with the greatest follow-up progression was selected; in non-progressors, the lesion with the greatest baseline stenosis was selected. This asymmetric rule incorporated follow-up information for progressors, a design choice the authors explicitly acknowledge as a limitation that limits prospective interpretation.

Lesion-specific PCAT segmentation and quantification were performed automatically using uAI-CoronaryCTA software after the target lesion had been identified. The longitudinal extent of the PCAT region of interest covered the full length of the target lesion, while the radial extent extended 3 mm outward from the outer vessel wall. Voxels with attenuation values ranging from -190 to -30 Hounsfield units (HU) were classified as adipose tissue. No post hoc kVp normalization was applied to the recorded mean PCAT attenuation values because patient-level tube-voltage and reconstruction metadata were unavailable. Consequently, these measurements should not be interpreted as voltage-normalized attenuation estimates, and the lack of scanner-specific metadata prevented assessment of scanner and reconstruction effects.

CT-FFR was calculated automatically using uAI Coronary Plaque Analysis software from the CCTA-derived three-dimensional coronary model. The value recorded for analysis was located at a standardized position 10 mm distal to the target lesion. Values ranged from 0 to 1, with lower values indicating greater estimated hemodynamic impairment. The target-lesion identification preceded the automated calculation and was not performed by the software itself. This separation ensures that the functional metric was derived from the anatomical model but quantified independently of the selection rule, although the selection rule itself remained outcome-dependent.

Five logistic regression models were specified in the statistical analysis plan before reanalysis fitting and fitted to a common complete-case population of 191 patients, comprising 109 progressors and 82 non-progressors. Model E, the most comprehensive model, retained nine prespecified predictors: age, sex, hypertension, diabetes mellitus, smoking history, baseline stenosis category, high-risk plaque, mean PCAT attenuation, and CT-FFR. No univariable screening or stepwise selection was used. Effects were scaled per 10-year increase in age, per 10-HU increase in PCAT attenuation toward less-negative values, and per 0.05 decrease in CT-FFR. This prespecified sequence allowed the researchers to address the associations and incremental contribution of PCAT and CT-FFR beyond clinical and conventional CCTA variables.

In Model E, less-negative mean PCAT attenuation remained associated with progression, with an odds ratio of 1.552 per 10-HU increase (95% CI, 1.137–2.119; P = 0.006). Lower CT-FFR was also associated with progression, with an odds ratio of 1.360 per 0.05 decrease (95% CI, 1.041–1.778; P = 0.024). Age showed an inverse conditional association, with an odds ratio of 0.509 per 10-year increase (95% CI, 0.346–0.749; P < 0.001). The remaining prespecified covariates were retained regardless of statistical significance. The apparent AUC for Model E was 0.767, and the optimism-corrected AUC was 0.722, indicating moderate discrimination. The corrected Brier score was 0.217, and the calibration slope was 0.779, suggesting some degree of optimism and coefficient overfitting.

When comparing nested models, adding mean PCAT attenuation and CT-FFR to the clinical and conventional CCTA model (Model B) improved overall model fit, with a likelihood-ratio test P value of less than 0.001. The apparent increase in AUC was 0.055, but the Holm-adjusted P value for the paired DeLong test was 0.165, indicating that the multiplicity-adjusted evidence for incremental discrimination was not statistically significant. After optimism correction, the change in AUC was 0.053 (95% CI, -0.005 to 0.088), crossing zero. Thus, while the combined model showed apparent performance improvement, evidence for incremental discrimination remained uncertain. The corrected Brier score decreased by 0.0143, suggesting lower prediction error, but the wide confidence intervals underscore the uncertainty in these estimates.

Sensitivity analyses were conducted to assess the robustness of the findings. The directions of the age, mean PCAT, and CT-FFR coefficients were preserved in ridge analysis and multiple-imputation analysis, as well as after additional adjustment for the systemic immune-inflammation index (SII), BMI, LDL-C, and PCAT volume. In the SII-complete subset, the SII-extended model yielded an odds ratio per doubling of SII of 0.596, indicating an inverse association. Restricted cubic spline analyses did not identify strong evidence of nonlinearity for age, mean PCAT, or CT-FFR. However, single-case deletion analyses revealed that removal of one patient changed the magnitude of the CT-FFR coefficient by 28.17%, although its direction was not reversed. This influence finding supports cautious interpretation of the CT-FFR association.

The study has several significant limitations. First, the outcome-dependent lesion selection could magnify associations and model performance, and internal validation cannot remove this design bias. The single selected-lesion record per patient did not reconstruct whole-coronary disease extent or allow independent confirmation of all non-target baseline segments. Second, progression required crossing a stenosis category, meaning small changes near a boundary might reflect measurement variation. Third, scanner and reconstruction heterogeneity could affect PCAT and CT-FFR, and mean PCAT attenuation was not normalized for kVp. Fourth, medication exposure, disease extent, and disease duration could not be adjusted for, and a single recorded baseline SII limited interpretation of inflammatory markers. Fifth, the cohort was modest in size and single-center, with no documented a priori sample-size calculation. Sixth, the endpoint was imaging-defined stenosis progression, not clinical events such as myocardial infarction or death. No clinical management action or treatment effect was tested, and the nomogram and decision curves remain exploratory.

The authors conclude that less-negative lesion-specific mean PCAT attenuation and lower CT-FFR were associated with imaging-defined coronary stenosis progression in this retrospective selected-lesion analysis. The prespecified combined model showed moderate optimism-corrected discrimination, while evidence for incremental discrimination remained uncertain. Because target-lesion selection in progressors incorporated follow-up information and external validation was unavailable, the model should be regarded as an internally derived exploratory risk-stratification construct rather than a clinically validated decision tool. Future studies should establish an outcome-independent baseline lesion-selection rule, standardize scanner and reconstruction parameters, and assess PCAT reproducibility to determine if these imaging markers can be transported across settings for clinical use.

Subject of Research: Associations of lesion-specific pericoronary adipose tissue attenuation and CT-derived fractional flow reserve with coronary stenosis progression

Article Title: Associations of lesion-specific pericoronary adipose tissue attenuation and CT-derived fractional flow reserve with coronary stenosis progression: a retrospective selected-lesion study

Article References: Wang, J., Song, K., He, S., Chen, S., Hou, Y., Chen, W., Liu, J., Feng, L., Wei, W., & Jiang, Z. (2026). Associations of lesion-specific pericoronary adipose tissue attenuation and CT-derived fractional flow reserve with coronary stenosis progression: a retrospective selected-lesion study. Frontiers in Cardiovascular Medicine, 13, Article 1954142. https://doi.org/10.3389/fcvm.2026.1954142

Image Credits: AI Generated

DOI: 10.3389/fcvm.2026.1954142

Keywords: coronary artery disease, pericoronary adipose tissue, CT-FFR, stenosis progression, coronary computed tomography angiography, retrospective study, lesion-specific imaging, hemodynamic impairment, plaque characterization, internal validation, bootstrap resampling, logistic regression, non-obstructive disease, cardiovascular risk, imaging biomarkers, single-center study, outcome-dependent selection, calibration slope, optimism-corrected AUC, clinical decision support

News Source: Ophelia Keating. (November 14, 2026). Fat Tissue Attenuation and CT-FFR Linked to Coronary Progression. Scienmag.

Tags: bootstrap resamplingcalibration slopecardiovascular riskClinical decision supportCoronary artery diseasecoronary computed tomography angiographyCT-FFRhemodynamic impairmentimaging biomarkersinternal validationlesion-specific imaginglogistic regressionnon-obstructive diseaseoptimism-corrected AUCoutcome-dependent selectionpericoronary adipose tissueplaque characterizationRetrospective studysingle-center studystenosis progression
Share12Tweet7Share2ShareShareShare1

Related Posts

Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

November 17, 2026
Pre-Curing Rheology Enables Electrospun Silicone Elastomer Coatings for Cochlear Implants

Pre-Curing Rheology Enables Electrospun Silicone Elastomer Coatings for Cochlear Implants

November 17, 2026

Triglyceride-Glucose Index Associated With Non-Alcoholic Fatty Liver Disease in Iranian Cohort

November 17, 2026

Global Longitudinal Strain Fails to Predict Structural Recovery After Aortic Stenosis Surgery

November 17, 2026

POPULAR NEWS

  • Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    29 shares
    Share 12 Tweet 7
  • Review Links Skin Microbiota and T-Cell Crosstalk to Venous Disease Progression

    29 shares
    Share 12 Tweet 7
  • Pre-Curing Rheology Enables Electrospun Silicone Elastomer Coatings for Cochlear Implants

    29 shares
    Share 12 Tweet 7
  • Solvothermal Synthesis Yields Bismuth Selenide Nanoparticles with Distinct Phonon Modes

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

Review Links Skin Microbiota and T-Cell Crosstalk to Venous Disease Progression

Pre-Curing Rheology Enables Electrospun Silicone Elastomer Coatings for Cochlear Implants

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.